Open Label Study For Ayurvedic Treatment On Parkinsons Disease.

Study Open Label Pilot study Of An Ayurvedic Treatment Regime On Levodopa Non-responding Parkinsonism (kampavata).

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027705

Enrollment

Registered

2020-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

Intervention1: single arm trial: Open Label Pilot Study Of An Ayurvedic Treatment Regime On Levodopa Non-responding Parkinsonism for 90 days. basti treatment- 400ml for 10 days Route of administratio

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with parkinsons for atleast 1 year and on stable treatment for parkinsonism. 2. Participant who will understand and will be ready to be part of the study 3. Participant who is ready to come for follow up visits

Exclusion criteria

Exclusion criteria: 1. Participant suffering from more than 2 uncontrolled chronic medical disorders. 2. Participant under steroid drug therapy 3. Participants with dementia. 4. Participants with history of CV stroke. 5. Participants with known history of allergy to experimental medication. 6. Participants with deformity who cannot undergo the YOGA and other required therapy.

Design outcomes

Primary

Measure	Time frame
The study result may be beneficial to patient suffering from parkinsonism. The study will help us to determine the role of a specific treatment regimen comprising of a mix of physical, nutritional and medication form in treatment of Parkinsonism within 90 days. Timepoint: The study result may be beneficial to patient suffering from parkinsonism. The study will help us to determine the role of a specific treatment regimen comprising of a mix of physical, nutritional and medication form in treatment of Parkinsonism within 90 days	—

Measure

Time frame

The study result may be beneficial to patient suffering from parkinsonism. The study will help us to determine the role of a specific treatment regimen comprising of a mix of physical, nutritional and medication form in treatment of Parkinsonism within 90 days. Timepoint: The study result may be beneficial to patient suffering from parkinsonism. The study will help us to determine the role of a specific treatment regimen comprising of a mix of physical, nutritional and medication form in treatment of Parkinsonism within 90 days

—

Secondary

Measure	Time frame
Evaluate the effectiveness of a structured Ayurveda treatmentTimepoint: Evaluate the effectiveness of a structured Ayurveda treatment within 90 days	—

Countries

India

Contacts

Public ContactDr Sunil Khandare

INDU Ayurveda Hospital

drsrkhandare@gmail.com9421363088

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026